Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Alan M Walfield"'
Autor:
Po-Ren Hsueh, Chuan-Liang Kao, Cun-Nan Lee, Li-Kuan Chen, Mei-Shian Ho, Charles Sia, Xin De Fang, Shugene Lynn, Tseng Yuan Chang, Shi Kau Liu, Alan M. Walfield, Chang Yi Wang
Publikováno v:
Emerging Infectious Diseases, Vol 10, Iss 9, Pp 1558-1562 (2004)
A peptide-based enzyme-linked immunosorbent assay (ELISA) can be used for retrospective serosurveillance of severe acute respiratory syndrome (SARS) by helping identify undetected chains of disease transmission. The assay was developed by epitope map
Externí odkaz:
https://doaj.org/article/6a36150aea354ec5979c95eae4330869
Autor:
Kelly Dong, Alan M. Walfield, Roger Grimson, Kenneth A. Smiles, Daniel B. Yarosh, Matthew T. Canning
Publikováno v:
Journal of Cosmetic Dermatology. 6:83-88
Summary Background Long-term treatment with a high-strength hydroquinone (HQ) cream (usually 4% HQ) is the mainstay therapy for hyperpigmentation disorders. Instability and high potential for irritancy hinders patient compliance. A new 4% HQ preparat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8cf62b26c3292a5e73eddc40e004c0f
https://doi.org/10.1111/j.1473-2165.2007.00301.x
https://doi.org/10.1111/j.1473-2165.2007.00301.x
Autor:
Chang Yi Wang, Alan M Walfield
Publikováno v:
Vaccine. 23:2049-2056
United Biomedical, Inc. (UBI) has developed a set of core technologies for the discovery and production of synthetic peptide-based immunotherapeutics and vaccines. These core technologies have led to products that stimulate functional site-directed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::580ce819fa65ea0b23668b06dfc33efb
https://doi.org/10.1016/j.vaccine.2005.01.007
https://doi.org/10.1016/j.vaccine.2005.01.007
Autor:
Xin De Fang, Po-Ren Hsueh, Li Kuan Chen, Alan M. Walfield, Chuan-Liang Kao, Tseng Yuan Chang, Charles Sia, Mei-Shang Ho, Chun Nan Lee, Shi Kau Liu, Shugene Lynn, Chang Yi Wang
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 10, Iss 9, Pp 1558-1562 (2004)
Emerging Infectious Diseases, Vol 10, Iss 9, Pp 1558-1562 (2004)
A standardized and rapid peptide-based SARS assay is characterized for sensitivity and specificity.
A peptide-based enzyme-linked immunosorbent assay (ELISA) can be used for retrospective serosurveillance of severe acute respiratory syndrome (SA
A peptide-based enzyme-linked immunosorbent assay (ELISA) can be used for retrospective serosurveillance of severe acute respiratory syndrome (SA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0484b64bcb1de37d09b6afbe739eb769
http://europepmc.org/articles/PMC3320307
http://europepmc.org/articles/PMC3320307
Autor:
Carl V. Hanson, Xin De Fang, Fan Shen, Xuan Mao Li, John Ye, James J. G. Wang, Gary Tam, Michael H. Shearer, Alan M Walfield, Maria Salas, Chang Yi Wang, Ming Lie Li, Ronald C. Kennedy, Ming Shen
Publikováno v:
Vaccine. 21:89-97
A class of synthetic peptide immunogens for the cell surface HIV receptor complex has been developed to elicit antibodies that block viral entry by inhibiting gp120-CD4 interaction. These peptides extend our HIV receptor-directed approach from passiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d098e9bde555fb2873dd3c5421997a17
https://doi.org/10.1016/s0264-410x(02)00432-2
https://doi.org/10.1016/s0264-410x(02)00432-2
Autor:
Alan M Walfield, Tseng Yuan Chang, Ed Kramer, Yeou Liang Lin, Chang Yi Wang, Ming Shen, Shih Ping Chen, Fred Brown, Ming Chang Li, Ping Cheng Yang, Nancy Chyr, Ming Hwa Jong, John Ye
Publikováno v:
Vaccine. 20:2603-2610
We have designed a peptide-based vaccine for foot-and-mouth disease (FMD) effective in swine. The peptide immunogen has a G–H loop domain from the VP1 capsid protein of foot-and-mouth disease virus (FMDV) and a novel promiscuous T helper (Th) site
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9326fc3802b1890cfa9b3c352c628d3
https://doi.org/10.1016/s0264-410x(02)00148-2
https://doi.org/10.1016/s0264-410x(02)00148-2
Autor:
James J. G. Wang, John R. Mascola, Rosanne Boyle, Ming Shen, Mary Salas, Chang Yi Wang, Marie Claire Gauduin, Lynette S. W. Sawyer, Richard A. Koup, Pei De Chen, Krishna K. Murthy, John Ye, Xinde Fang, Alan M Walfield, Wayne C. Koff, Ming Lie Li, David C. Montefiori, Carl V. Hanson
Publikováno v:
Proceedings of the National Academy of Sciences. 96:10367-10372
mAb B4 is a monoclonal antibody directed against HIV receptor complex. The antibody had broad neutralizing activity against HIV and provided postexposure prophylaxis to hu–peripheral blood leukocyte (PBL)–severe combined immunodeficient mice and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ab0041154354cff5232159a6738dca5
https://doi.org/10.1073/pnas.96.18.10367
https://doi.org/10.1073/pnas.96.18.10367
Autor:
David Looney, Barbara Hosein, Alan M. Walfield, James P. Tam, M.-L. Li, Flossie Wong-Staal, J Ye, Chang Yi Wang
Publikováno v:
Science. 254:285-288
A titer for homologous viral neutralization activity (greater than 1:19,683) was observed after a 3.5-year immunization period with an octameric, branching peptide representing the principal neutralizing determinant (PND) of the human immunodeficienc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3769a97d6561a0c8f73b1bea336bca1b
https://doi.org/10.1126/science.1925584
https://doi.org/10.1126/science.1925584
Autor:
Charles Sia, Manfred Windisch, Alan M Walfield, Tseng-Yuan Chang, Chang Yi Wang, Chung Ho Hung, Kenneth K. Sokoll, Birgit Hutter-Paier, Connie L. Finstad, Xin De Fang
Publikováno v:
Vaccine. 25(16)
The UBITh ® AD immunotherapeutic vaccine for Alzheimer’s disease uses an amyloid- (A) immunogen having two designer peptides that have been engineered to elicit anti-N terminal A1–14 antibodies while minimizing potential for the generation of ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4739797777a68c769bd23aea54006d1d
https://pubmed.ncbi.nlm.nih.gov/17287052
https://pubmed.ncbi.nlm.nih.gov/17287052
Autor:
Wayne C. Koff, Jacek Kowalski, Connie L. Finstad, Krishna K. Murthy, Wei Guo Xia, Chang Yi Wang, Timothy J. Zamb, Meilun Zhang, Xuan Mao Li, Alan M Walfield, Ming Lie Li, Maarten C. Bosland
Publikováno v:
Vaccine. 22(9-10)
We have designed a peptide-based immunotherapeutic vaccine for treatment of androgen-responsive prostate cancer. The vaccine targets the luteinizing hormone-releasing hormone (LHRH) decapeptide that results in an androgen-deprivation immunotherapy. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e167f8dd21cd6cd3e9a9499d047a6e
https://pubmed.ncbi.nlm.nih.gov/15003660
https://pubmed.ncbi.nlm.nih.gov/15003660